View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 24-May-2023 / 12:10 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 22-May-2023 / 12:51 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 19-May-2023 / 13:16 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 18-May-2023 / 13:08 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 17-May-2023 / 13:24 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 16-May-2023 / 12:30 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 15-May-2023 / 12:49 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 11-May-2023 / 12:45 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) The Vanguard Group, Inc.: Mediclinic International plc 10-May-2023 / 12:47 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s)...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 08-May-2023 / 13:11 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 04-May-2023 / 12:40 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 28-Apr-2023 / 13:04 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 27-Apr-2023 / 15:06 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 26-Apr-2023 / 14:52 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 26-Apr-2023 / 14:35 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 25-Apr-2023 / 12:59 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 19-Apr-2023 / 12:42 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 18-Apr-2023 / 13:05 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 17-Apr-2023 / 13:21 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 14-Apr-2023 / 12:55 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch